Barbara Ryan, Director of MiNK Therapeutics INKT, has filed 3 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $17.9K. The latest trade was on 06/04.

BR

BR

Barbara Ryan

Director

Company

MiNK Therapeutics INKT

First filing

23/03/03

Trades

34 trades

Buys / sales

3 / 8

12-month net buying

−$17.9K

Last trade

06/04

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
MiNK TherapeuticsINKT	Open-market sale	06/04	06/05	1,500 sh2 trades	$12.76avg.	$19,140	−6.4%
Indivior PharmaceuticalsINDV	Open-market buy	03/13	03/13	8 sh	$31.09	$248.72	+0.1%
MiNK TherapeuticsINKT	Open-market sale	03/09–03/10	03/11	1,500 sh4 trades	$14.70avg.	$22,053	−6.8%
Indivior PharmaceuticalsINDV	Open-market buy	03/09	03/11	31 sh	$32.56	$1,009.36	+0.5%
MiNK TherapeuticsINKT	Open-market sale	02/27–03/02	03/04	500 sh2 trades	$10.85avg.	$5,427	−2.2%
Indivior PharmaceuticalsINDV	Open-market buy10b5-1 plan	01/05	01/07	775 sh	$35.39	$27,427.25	+65.2%